Leaderboards/Aortic Disease and Treatment Approaches

Aortic Disease and Treatment Approaches

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Mohamed Elmarasi
Hamad Medical Corporation
2
Jacob Rogatinsky
Boston University
3
Anders Wanhainen
Unknown
4
Ahmed Eleshra
Universität Hamburg
5
Luca Rosalia
Harvard–MIT Division of Health Sciences and Technology
6
Yujian Hu
First Affiliated Hospital Zhejiang University
7
Karl Teurneau-Hermansson
Lund University
8
Nicholas Goel
University of Pennsylvania
9
Shufen Zheng
Fudan University
10
Malte Rolf‐Pissarczyk
Graz University of Technology

Papers

1
Phenotypic switching of vascular smooth muscle cells in atherosclerosis, hypertension, and aortic dissection
Journal of Cellular Physiology|2024
116 cit.
2
Abdominal aortic aneurysm and cardiometabolic traits share strong genetic susceptibility to lipid metabolism and inflammation
Nature Communications|2024
54 cit.
3
Publication in European Journal of Vascular and Endovascular Surgery (2025) [44 citations, W7116972587]
European Journal of Vascular and Endovascular Surgery|2025
44 cit.
4
Publication in Progress in Materials Science (2024) [43 citations, W4402488032]
Progress in Materials Science|2024
43 cit.
5
Mortality after non-surgically treated acute type A aortic dissection is higher than previously reported
European Journal of Cardio-Thoracic Surgery|2024
42 cit.
6
Publication in The Annals of Thoracic Surgery (2025) [18 citations, W4406659497]
The Annals of Thoracic Surgery|2025
18 cit.
7
CAR-T cell therapy: Efficacy in management of cancers, adverse effects, dose-limiting toxicities and long-term follow up
International Immunopharmacology|2024
14 cit.
8
Soft robotic platform for progressive and reversible aortic constriction in a small-animal model
Science Robotics|2024
11 cit.
9
Publication in Journal of Thoracic and Cardiovascular Surgery (2024) [7 citations, W4400872085]
Journal of Thoracic and Cardiovascular Surgery|2024
7 cit.
10
Causes and clinical impact of initial misdiagnosis of acute type A aortic dissection
European Heart Journal Open|2025
6 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Ibrahim Sultan
University of Pittsburgh Medical Center
2
Maral Ouzounian
Toronto General Hospital
3
Isaac Wamala
Deutsches Herzzentrum der Charité
4
Markus A. Horvath
Boston Children's Hospital
5
Vladimir Matoussevitch
University of Cologne
6
Zhihui Dong
Hubei University of Medicine
7
Moritz C. Wyler von Ballmoos
Texas Health Harris Methodist Hospital Fort Worth
8
Randall R. DeMartino
University of California, Los Angeles
9
Roman Gottardi
Universitäts-Herzzentrum Freiburg-Bad Krozingen
10
Duanduan Chen
Southern University of Science and Technology

Papers

1
The Society of Thoracic Surgeons 2023 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation
The Annals of Thoracic Surgery|2024
87 cit.
2
Improved Outcomes Following the Ross Procedure Compared With Bioprosthetic Aortic Valve Replacement
Journal of the American College of Cardiology|2022
67 cit.
3
Moderate Aortic Valve Stenosis Is Associated With Increased Mortality Rate and Lifetime Loss: Systematic Review and Meta‐Analysis of Reconstructed Time‐to‐Event Data of 409 680 Patients
Journal of the American Heart Association|2024
40 cit.
4
Outcomes of emergency surgery for acute type A aortic dissection complicated by malperfusion syndrome
Journal of Thoracic and Cardiovascular Surgery|2022
35 cit.
5
Characterization of the microenvironment of diabetic foot ulcers and potential drug identification based on scRNA-seq
Frontiers in Endocrinology|2023
35 cit.
6
Fast Virtual Stenting for Thoracic Endovascular Aortic Repair of Aortic Dissection Using Graph Deep Learning
IEEE Journal of Biomedical and Health Informatics|2025
31 cit.
7
Acute Kidney Injury in Patients Undergoing Surgery for Type A Acute Aortic Dissection
The Annals of Thoracic Surgery|2022
30 cit.
8
Impact of Aortic Root Enlargement on Patients Undergoing Aortic Valve Replacement
The Annals of Thoracic Surgery|2022
29 cit.
9
Nanoparticles (NPs)-mediated systemic mRNA delivery to reverse trastuzumab resistance for effective breast cancer therapy
Acta Pharmaceutica Sinica B|2022
27 cit.
10
Hemiarch versus extended arch repair for acute type A dissection: Results from a multicenter national registry
Journal of Thoracic and Cardiovascular Surgery|2023
25 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
John A. Elefteriades
Yale University
2
Kim A. Eagle
University of Michigan
3
Hazim J. Safi
The University of Texas Health Science Center at Houston
4
David Williams
St George's, University of London
5
D. Craig Miller
Harvard University
6
Cathérine Boileau
Hôpital Necker-Enfants Malades
7
Harry C. Dietz
Johns Hopkins University
8
Victor Aboyans
The Princess Grace Hospital
9
Christoph Nienaber
St. Michael's Hospital
10
Joseph E. Bavaria
University of Pennsylvania

Papers

1
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
Nature Genetics|2003
3k cit.
2
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
Circulation|2010
2.3k cit.
3
Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene
Nature|1991
2.1k cit.
4
Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
Science|2006
1.8k cit.
5
A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2
Nature Genetics|2005
1.8k cit.
6
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
Journal of the American College of Cardiology|2010
1.7k cit.
7
ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—executive summary
Journal of the American College of Cardiology|2002
1.7k cit.
8
Aneurysm Syndromes Caused by Mutations in the TGF-β Receptor
New England Journal of Medicine|2006
1.6k cit.
9
A Validated Prediction Model for All Forms of Acute Coronary Syndrome
JAMA|2004
1.6k cit.
10
Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome
Nature Genetics|2003
1.4k cit.

Reagents for Aortic Disease and Treatment Approaches

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling Technology

MHC Class I (EMR8-5) Mouse Monoclonal Antibody (BSA and Azide Free)

#28149$865
View Evidence →
Cell Signaling TechnologyEvidence 65

Whitlow/218 Linker (E3U7Q) Rabbit Monoclonal Antibody (Alexa Fluor® 647 Conjugate)

#69310$5,131,466
View Evidence →
Cell Signaling TechnologyEvidence 67

Phospho-beta-Catenin (Ser45) Antibody

#9564$366
View Evidence →

🌟 All-Time

Most validated

AbcamEvidence 60

Anti-TAGLN/Transgelin antibody

Cited in 5 papers
#ab14106
View Evidence →
Cell Signaling Technology

CAND1 (D1F2) Rabbit Monoclonal Antibody

Cited in 5 papers
#8759$161,351
View Evidence →
Santa Cruz BiotechnologyEvidence 60

alpha-Actin (1A4)

#sc-32251
View Evidence →